The abstract is read at the publisher; the summary is JClub's.
A Balanced Readiness Level review of 77 agricultural biotechnologies finds market viability and social acceptance are the primary constraints, not technological readiness.
- Why it matters: Early-stage biotech options could reduce agriculture’s environmental harm, but without a systematic deployability check, promising tools may be misprioritized.
- What they did: The authors scored 77 biotechnologies across eight domains using a Balanced Readiness Level framework covering technological, market, regulatory, acceptance, and organizational dimensions, and added a Fermi analysis for microbial fertilizers.
- The result: High-readiness options are typically “drop-in,” contained, transient, and viewed as natural, implying deployability strategies like improving genetically modified organism containment and motivating further quantitative scalability and environmental-impact analysis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.